arrow
E

Elena Muraro

irccs aviano (cro)
H指数:22
被引数:1,409

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Radical hemithorax radiotherapy induces an increase in circulating PD-1+ T lymphocytes and in the soluble levels of PD-L1 in malignant pleural mesothelioma patients: a possible synergy with PD-1/PD-L1 targeting treatment?

根治性半胸放射治疗可诱导恶性胸膜间皮瘤患者循环PD-1<sup>+</sup>T淋巴细胞数量增加,并提高可溶性PD-L1水平:这可能与其与PD-1/PD-L1靶向治疗的协同作用有关?

2025-04-010
OA
Antibody dependent cellular cytotoxicity-inducing anti-EGFR antibodies as effective therapeutic option for cutaneous melanoma resistant to BRAF inhibitors
2024-03-060
OAAI
Integration of Cellular and Humoral Immune Responses as an Immunomonitoring Tool for SARS-CoV-2 Vaccination in Healthy and Fragile Subjects
2023-05-300
OAAI
COVID-19 vaccination: Evaluation of humoral and cellular immunity after the booster dose in chronic lymphocytic leukemia patients
2023-01-091
OA
Prognostic Nutritional Index Predicts Toxicity in Head and Neck Cancer Patients Treated with Definitive Radiotherapy in Association with Chemotherapy

预后营养指数预测接受确定性放疗联合化疗的头颈部癌症患者的毒性

2021-04-1332
OAAI
Radical Hemithoracic Radiotherapy Versus Palliative Radiotherapy in Non-metastatic Malignant Pleural Mesothelioma: Results from a Phase 3 Randomized Clinical Trial
2021-04-0111
PREAI
Clinical and Antitumor Immune Responses in Relapsed/Refractory Follicular Lymphoma Patients after Intranodal Injections of IFNα-Dendritic Cells and Rituximab: a Phase I Clinical Trial
2019-09-0333
OAAI
Lymphomagenic properties of a HIV p17 variant derived from a splenic marginal zone lymphoma occurred in a HIV-infected patient

在HIV感染的患者中发生了源自脾边缘区淋巴瘤的HIV p17变体的淋巴组织特性

2018-11-067
OAAI